MPLT
MapLight Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.00
+3.90%Next report
Analyst consensus
- Next report date
- Dec 3, 2026
- EPS estimate
- -$1.22
- Revenue estimate
- —
Latest reported
- Last report date
- Sep 18, 2026
- EPS actual
- -$1.32
- EPS estimate
- -$1.35
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -563.9%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $29
- PT range
- $13 – $46
- Analysts
- 7
4 Buy3 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Sep 18, 2026 | -$1.35 | -$1.32 | Beat 2.15% | — |
| May 14, 2026 | -$0.96 | -$1.34 | Miss -39.29% | — |
| Mar 26, 2026 | -$0.96 | -$2.47 | Miss -156.76% | — |
| Dec 4, 2025 | -$1.72 | -$37 | Miss -2061.63% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 3, 2026